Skip to main content

Advertisement

Log in

Hodgkin lymphoma in a sickle cell anaemia child treated with hydroxyurea

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 332:1317–1322 doi:10.1056/NEJM199505183322001

    Article  PubMed  CAS  Google Scholar 

  2. Ferster A, Sariban E, Meuleman N, Belgian Registry of Sickle Cell Disease patients treated with Hydroxyurea (2003) Malignancies in sickle cell disease patients treated with hydroxyurea. Br J Haematol 123:368–369 doi:10.1046/j.1365-2141.2003.04614.x

    Article  PubMed  Google Scholar 

  3. Hanft VN, Fruchtman SR, Pickens CV, Rosse WF, Howard TA, Ware RE (2000) Acquired DNA mutations associated with in vivo hydroxyurea exposure. Blood 95:3589–3593

    PubMed  CAS  Google Scholar 

  4. Haute autorité de Santé. Recommandations pour la pratique clinique. Prise en charge de la drépanocytose chez l’enfant et l’adolescent. Septembre 2005. Available at http://www.has-sante.fr/portail/upload/docs/application/pdf/Drepanocytose_reco.pdf

  5. de Montalembert M (2004) Management of sickle cell disease. Rev Prat 54:1557–1564

    PubMed  Google Scholar 

  6. de Montalembert M, Brousse V, Elie C, Bernaudin F, Shi J, Landais P, French Study Group on Sickle Cell Disease (2006) Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes. Haematologica 91:125–128

    PubMed  Google Scholar 

  7. Moschovi M, Psychou F, Menegas D, Tsangaris GT, Tzortzatou-Stathopoulou F, Nikolaidou P (2001) Hodgkin’s disease in a child with sickle cell disease treated with hydroxyurea. Pediatr Hematol Oncol 18:371–376 doi:10.1080/088800101316921985

    Article  PubMed  CAS  Google Scholar 

  8. Schultz WH, Ware RE (2003) Malignancy in patients with sickle cell disease. Am J Hematol 74:249–253 doi:10.1002/ajh.10427

    Article  PubMed  Google Scholar 

  9. Wilson S (2000) Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea. Ann Intern Med 133:925–926

    PubMed  CAS  Google Scholar 

  10. Zimmerman SA, Schultz WH, Davis JS, Pickens CV, Mortier NA, Howard TA, Ware RE (2004) Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood 103:2039–2045 doi:10.1182/blood-2003-07-2475

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. P. Vannier.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Couronné, L., Schneider, P., de Montalembert, M. et al. Hodgkin lymphoma in a sickle cell anaemia child treated with hydroxyurea. Ann Hematol 88, 597–598 (2009). https://doi.org/10.1007/s00277-008-0632-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-008-0632-3

Keywords

Navigation